Epsilon-poly-lysine capsules

a technology of lysine capsules and lysine, which is applied in the field of capsules, can solve the problems of high cost of -poly-l-lysine, inability to optimally biocompatibility of apa microcapsules, and drawbacks of producing such capsules, and achieve the effect of improving buoyancy and decreasing tendency

Inactive Publication Date: 2012-10-11
MICROPHARMA
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patented technology prevents bacteria from infecting cells by adding certain substances that make them lighter than water. This makes it easier for these microorganisms to hide within their own body when they are alive.

Problems solved by technology

This patent describes methods for creating microcapsules containing substances like drugs, proteins, nucleic acids, and living organisms. These techniques involve embedding them in an insoluble hydrogel called alginate, which acts as a barrier against environmental factors like oxygen and nitrogen. Microcapsules made of these materials help keep certain ingredients alive but also make it difficult to pass through the skin due to its impervious nature. To overcome this problem, the patent proposes introducing a new type of shell called lipid-immobilized microcells (LIMCS). These microparticles contain specific chemical entities attached to the outside of the alginate network, providing better stability and protection against harmful agents.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Epsilon-poly-lysine capsules
  • Epsilon-poly-lysine capsules
  • Epsilon-poly-lysine capsules

Examples

Experimental program
Comparison scheme
Effect test

example 1

Morphology and Structural Properties of AεPA Versus AαPA Microcapsules

[0156]Preparation of APA microcapsules for transmission electron microscopy (TEM):

To prepare and fix the AαPA or AεPA microcapsules in preparation for TEM, microcapsules were washed (×3) with buffer for 30 min., post-fixed with 1% aqueous OsO4, and 1.5% aqueous potassium ferrocyanide for 2 h at 4° C. The samples were then washed (3×) with ddH2O for 15 min., dehydrated with acetone: 30%, 50%, 70%, 80%, 90%, (3×) 100% each for 15 min. and infiltrated with epon / acetone 1:1 overnight, 2:1 all day, 3:1 overnight, pure epon the following day for day 4 h. Samples were then embedded with a change of fresh epon., polymerization in 58° C. oven for 4 h. The samples were trimmed and cut into 90-100 nm thick sections, put onto a 200 mesh copper grid, sections on grids were stained with uranyl acetate for 6 minutes and then Reynold's lead for 5 min.

Specimen Preparation for SEM:

[0157]Samples previously stored in 0.85% saline were

example 2

Bacteriosatic Effects of Free ε-PLL Versus α-PLL on Probiotic Bacteria and Viability of AαPA Versus AεPA Microencapsulated Probiotic Bacteria

Bacterial Growth in Presence of α / ε-PLL:

[0165]α-poly-L-lysine and ε-poly-L-lysine stock solutions of 0.8% (w / v) were filter sterilized and diluted to the appropriate concentrations (e.g. 0.05% a / ε-PLL (1.25 mL 0.8% (w / v) PLL+18.75 mL MRS). 20 ml MRS was used as control. A 1% (v / v) inoculum (200 μL) of overnight growing culture was added to each 20 ml solution. Incubation was performed at 37° C. and samples were performed at 0, 1, 2, 3, 4, 5, 6, 7, 8, 24 hours. At each time point, 100 μL of sample was removed from the incubating medium for determination of cell viability. Colony forming units (cfu) / ml were measured as indication of cell viability.

Inhibitory Effect of PLL on Bacterial Growth:

[0166]To determine the inhibitory effect of increasing concentrations on bacterial growth of Lactobacillus reuteri NCIMB 701089, 25 mL stock solutio

example 3

BSH Activity of AαPA Versus AεPA Microencapsulated Lactobacillus Reuteri NCIMB 701089

Assessment of BSH Activity of Microencapsulated Cells:

[0171]To assess the enzymatic activity of α-PLL or ε-PLL microencapsulated bile salt hydrolase (BSH) active probiotic bacteria, BSH activy was determined by HPLC. Microcapsules were washed 3 times with 3 volumes of sterile 0.85% saline in a mesh bottomed beaker to remove all traces of storage media. Once washed, the microcapsules were divided into 2.5 g samples and resuspended in 2 ml MRS. The suspension was added to 18 ml of MRS containing 5 mM taurodeoxycholic acid (TDCA) (Sigma, St Louis) and 5 mM glycodeoxycholic acid (GDCA) (Sigma, St Louis). Samples were taken out at 0.5, 1, 3, and 5 hours after the samples were placed in the 37° C. incubator. The amount of GDCA and TDCA remaining in the samples was analyzed by HPLC. Analyses were performed on a reverse-phase C-18 column (LiChrosorb RP-18 250 nm×4.6 mm, 5 μm) at a flow rate of 1.0 ml / min. Th

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Fractionaaaaaaaaaa
Timeaaaaaaaaaa
Login to view more

Abstract

The present disclosure relates to capsules having a core and one or more capsular walls surrounding the core, wherein at least one of the capsular walls comprises a polymer comprising epsilon-poly-lysine or a derivative thereof.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner MICROPHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products